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Yoann Baudoin, MD, Kevin Guilhem, MD, Leon Meyrat, MD, and Hervé Thouard, MD, Toulon, FranceWe report a case of a 52-year-old woman with no previous vascular disease and no
vascular risk factor. She developed in a few weeks a progressive occlusive arterial
disease of lower limbs Leriche-Fontaine (stage IIB). Anamnesis revealed the intro-
duction of methysergide, an ergot alkaloid, 30 months earlier for migraine attack
prevention. The computed tomography angiography (A and B) showed a long
stenosis of the right external iliac artery (70%) and a short stenosis (70%-80%) of
the left external iliac artery. All other investigations found no inﬂammatory disease
or argument for atheromatous disease.
We decided to exclude methysergide, to introduce clopidogrel, and to prescribe
zolmitriptan for migraine attacks. Under this treatment, symptoms gradually
decreased and disappeared in 4 months, with a follow-up of 24 months. The
control computed tomography angiography (C and D) showed a restitutio ad
integrum of the 2 iliac arteries.
Arterial spasm is a recognized complication of ergot alkaloids. This can affect
various arteries: cerebral, coronary, mesenteric, and arteries in both extremities.1-3
Episodes of toxicity referred to as St. Anthony’s ﬁre related to ergot intoxication
have been described since the middle ages.1 Furthermore, the knowledge of
previous treatment by ergot alkaloids is the key point to avoid in stenting of these
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